Prothena Corporation PLC (NASDAQ:PRTA)

37.84
Delayed Data
As of Mar 27
 +1.28 / +3.50%
Today’s Change
16.71
Today|||52-Week Range
45.00
+82.27%
Year-to-Date

Today’s Trading

Previous close36.56
Today’s open36.41
Day’s range36.14 - 38.36
Volume385,231
Average volume (3 months)411,721
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+86.82%
Earnings growth (this year)--
Earnings growth (next 5 years)-134.72%
Revenue growth (last year)+7,422.78%
P/E ratioNM
Price/Sales10.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc+0.07+0.95%
TXMDTherapeuticsMD Inc+0.18+3.09%
ARNAArena Pharmaceutical...-0.01-0.23%
FOLDAmicus Therapeutics ...+0.29+2.72%
Data as of 4:01pm ET, 03/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$50.9M
Annual profit (last year)-$7.2M
Net profit margin-14.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Dale B. Schenk
Chief Financial Officer &
Head-Investor Relations
Tran B. Nguyen
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account